ESTEPAN IAN MICHAEL (Chief Financial Officer) received a stock award from SAREPTA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/5/2025ACC: 0001193125-25-197423
Officer· Chief Financial Officer
Since Dec 2020
+143.88K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
143.88K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+93.88K
Price / share
—
Trade value
—
% of position
149.9%
9/3/2025
62.61K→156.49K
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
32.0%
9/3/2025
156.49K→206.49K
Total
Net shares
+143.88K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/3/2025 | A · Award | +93.88K | — | — | 149.9% | 62.61K | 156.49K |
| Common Stock Direct | 9/3/2025 | A · Award | +50K | — | — | 32.0% | 156.49K | 206.49K |
| Total | +143.88K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported